Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15201665rdf:typepubmed:Citationlld:pubmed
pubmed-article:15201665lifeskim:mentionsumls-concept:C0403592lld:lifeskim
pubmed-article:15201665lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:15201665lifeskim:mentionsumls-concept:C1441290lld:lifeskim
pubmed-article:15201665lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:15201665lifeskim:mentionsumls-concept:C1363844lld:lifeskim
pubmed-article:15201665pubmed:issue11lld:pubmed
pubmed-article:15201665pubmed:dateCreated2004-6-17lld:pubmed
pubmed-article:15201665pubmed:abstractTextThe precise mechanisms underlying the development of chronic allograft nephropathy (CAN) and the associated renal fibrosis remain uncertain. The protein-crosslinking enzyme, tissue transglutaminase (tTg), has recently been implicated in renal fibrosis. METHODS.: We investigated the involvement of tTg and its crosslink product, epsilon-(gamma-glutamyl) lysine, in 23 human kidney allografts during the early posttransplantation period and related these to changes of CAN that developed in 8 of them. Sequential biopsies were investigated using immunohistochemical, immunofluorescence, and in situ enzyme activity techniques.lld:pubmed
pubmed-article:15201665pubmed:languageenglld:pubmed
pubmed-article:15201665pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:citationSubsetIMlld:pubmed
pubmed-article:15201665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15201665pubmed:statusMEDLINElld:pubmed
pubmed-article:15201665pubmed:monthJunlld:pubmed
pubmed-article:15201665pubmed:issn0041-1337lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:El NahasA...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:GriffinMartin...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:JohnsonTimoth...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:BrownColin...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:WildGrahamGlld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:Abo-ZenahHamd...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:SkillJames...lld:pubmed
pubmed-article:15201665pubmed:authorpubmed-author:BexSamanthaSlld:pubmed
pubmed-article:15201665pubmed:issnTypePrintlld:pubmed
pubmed-article:15201665pubmed:day15lld:pubmed
pubmed-article:15201665pubmed:volume77lld:pubmed
pubmed-article:15201665pubmed:ownerNLMlld:pubmed
pubmed-article:15201665pubmed:authorsCompleteYlld:pubmed
pubmed-article:15201665pubmed:pagination1667-75lld:pubmed
pubmed-article:15201665pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:meshHeadingpubmed-meshheading:15201665...lld:pubmed
pubmed-article:15201665pubmed:year2004lld:pubmed
pubmed-article:15201665pubmed:articleTitleTissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?lld:pubmed
pubmed-article:15201665pubmed:affiliationSheffield Kidney Institute, Sheffield, UK. t.johnson@sheffield.ac.uklld:pubmed
pubmed-article:15201665pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15201665pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7052entrezgene:pubmedpubmed-article:15201665lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15201665lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15201665lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15201665lld:pubmed